Cargando...
Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
Lung cancer remains the leading cause of cancer-related death in men and women, despite its constantly declining rates in incidence and mortality in the developed world. The past decade has witnessed an unprecedented rise in the development of molecular targeted therapies in various types of tumors....
Guardado en:
| Publicado en: | Ann Transl Med |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952024/ https://ncbi.nlm.nih.gov/pubmed/29862231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.04.28 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|